Delivery System Performance Validation

Delivery system performance validation confirms pharmaceutical formulations achieve intended release profiles, bioavailability, and therapeutic efficacy. In vitro release testing measures active ingredient liberation from delivery systems under physiological conditions. Bioavailability studies in animal and human subjects confirm predicted exposure-response relationships. Comparative bioavailability assessment establishes equivalence to reference formulations.

Device functionality validation ensures delivery systems perform correctly throughout shelf life. Usability testing confirms patients can properly administer medications. Regulatory submissions incorporate comprehensive performance validation data. Post-approval monitoring detects formulation failures compromising performance. Emerging in vitro-in vivo correlation modelling improves predictive value of release testing.